Kidney transplants from young pediatric donors are uncommonly performed in the UK.
| INTRODUC TI ON
Renal transplantation is the best treatment option for patients with end-stage renal disease, conferring a significant survival advantage over dialysis. 1, 2 The demand for renal transplantation outstrips the availability of donor organs; only 2228 transplant procedures were performed in the United Kingdom (UK) in 2015-2016, with 5275 active patients on the waiting list during the same time period. 3 This imbalance has led to efforts to expand the donor pool. 4 Organ donation rates from the pediatric age group (0-18 years of age) is low and has remained static or proportionally reduced in the recent years. 3 Kidneys from donors younger than the age of 5 years or weighing less than 15 kg are usually offered, procured, and transplanted en bloc into an adult or adolescent recipient. 5 In the United Kingdom, there has been a general reluctance to utilize extremely young donor kidneys, mainly due to reported higher rates of early graft loss among other anxieties that have been described previously. 6, 7 The highest rate of pediatric mortality is observed in the neonatal period, accounting for 18.68 deaths per 1000 live births in 2015, globally. 8 This age group has seldom been considered for solid organ donation except for heart valves and more recently for hepatocytes. 9, 10 In 2014, Hanley et al sug- [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . 12 Until 2015, UK legislation also precluded the diagnosis of brainstem death (BSD) in infants younger than 2 months of age, which would have also contributed to the increased reluctance to utilize these organs.
13 Table 1 summarizes the published case series of renal transplantation reporting over 5 transplants from donors younger than 5 years of age. The reported 1-year graft survival rates range from 71.4% to 100%, the former in a cohort of pediatric recipients of en bloc kidney transplantation (EKT). 14 In 2015, Bent et al reported a graft arterial stenosis incidence rate of 1.1% from a cohort of 182
EKTs from donors aged 0-84 months and weighing 1.9-24 kg. 15 The same group also reported a higher risk (10 of 52) of graft thrombosis in EKTs from donors <5 kg compared to ≥5 kg donor EKT (7 of 140). 16 Their single-center series of EKTs from 65 paired donation after cardiac death (DCD) and donation after brain death (DBD) donors under 10 kg reported recently states 1-and 5-year death censored graft survival of 89% and 87%, respectively, for DCD grafts and 91% for DBD grafts at 1 and 5 years.
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In this study, we evaluated our single-center experience with
EKTs from young pediatric donors weighing less than 20 kg in and compared EKT outcomes from donors ≤5 kg to those from >5 kg donors.
| ME THODS
All EKTs from pediatric donors weighing less than 20 kg performed at our institution from January 1, 2005 to October 1, 2016, were identified from a prospective database and donor and recipient demographics were obtained. Electronic patient records were examined for follow-up details. All graft losses were verified with National Health Service Blood and Transplant (NHSBT) records.
| Definitions
For this study, small pediatric donors were divided into 2 groups; those weighing more than 5 kg and those weighing 5 kg or less.
Delayed graft function (DGF) was defined as a need for more than one session of dialysis in the immediate postoperative period.
Primary nonfunction (PNF) was defined as a lack of graft function at 6 months from time of transplantation, not attributable to an identifiable cause, with the recipient never being dialysis-free after transplant. The estimated glomerular filtration rate (eGFR) in the recipient was calculated using the Cockcroft-Gault equation.
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| Donor referral and selection
Once the medical team involved in the care of the potential donor had established futility treatment and/or diagnosed BSD, referral was made to the Specialist Nurse for Organ Donation (SNOD) for consideration of donation. SNODs from all 7 UK procurement regions contacted our center in most cases to discuss the suitability for donation and the kidneys were offered directly to our center.
In some instances, the kidneys were accepted at our center via the "fast-track organ allocation scheme" for declined kidneys that were offered to another or multiple centers initially. 19 If consent for donation was obtained, the National Organ Retrieval Service (NORS) was mobilized for organ procurement.
All donors older than 36 weeks of gestation with evidence of urine production after birth and a normal or normalizing serum creatinine were considered for donation. For donors accepted in utero, normal fetal growth, absence of oligohydramnios, presence of urine in the bladder, and an absence of congenital anomaly that affects kidneys were confirmed. For DCD donation, a maximum 3-hour agonal phase from withdrawal of life-sustaining treatment to onset of asystole was observed.
| Recipient selection
For each potential donor offer, an NHSBT "matching run" of all potential recipients on our center waiting list in rank order (center-specific matched recipient list) was requested. Our inclusion criteria for the recipients evolved and refined during the study period and included mainly young and middle-aged adults (up to the age 60) 
| Procurement, preservation, and implantation
All kidneys in this cohort were offered as en bloc pairs and were utilized for EKTs. None of the pairs were considered for single kidney transplant (SKT). Both kidneys and ureters were procured en bloc with aorta and inferior vena cava (IVC) down to and including aortic bifurcation with ureters procured with a cuff of bladder or divided close to the bladder. In the absence of liver or small bowel procurement, maximum length of suprarenal abdominal aorta (AA) and IVC were recovered.
The preferred solution for in situ flush and static cold storage (SCS) was
University of Wisconsin (UW) solution. Only gravity flush was used.
In the latter half of the study and in most cases of infant and neonatal donation, the initial flush was performed with 25-50 mL/kg Ringer's TA B L E 1 Published outcomes of EKT in the last 5 y from donors ages <5 y or <15 kg (unless specified) The implantation was performed routinely in the iliac fossa using an extraperitoneal approach ( Figure 1 ). Suprarenal AA and IVC or switched conduits were used for implantation at a right angle to the external iliac vessels in most cases. The orientation of the kidneys was reversed "back to front" to facilitate vascular anastomoses so that renal pelvis and ureters were readily accessible if future surgical intervention were required. Intraoperative heparin was not administered prior to reperfusion in this cohort. In all cases, ureters were implanted separately onto the bladder using "onlay" technique over double-J stents, which were removed at 6 weeks following transplant.
| Immunosuppression
All patients received standard induction immunosuppression with basiliximab (anti-CD25 receptor monoclonal antibody) or alemtuzumab (leukocyte-depleting anti-CD52 monoclonal antibody) with intravenous methylprednisolone 500 mg as per our local protocol. Maintenance immunosuppression included tacrolimus, mycophenolate mofetil (MMF),
and prednisolone in a basiliximab-based regimen and tacrolimus monotherapy in most cases of a alemtuzumab-based regimen. MMF (and occasionally prednisolone) was added to the latter if there were 2 haplotype DR2 mismatches, previous history of rejection, or when the patient was sensitized. A lower tacrolimus trough level of 4-9 ng/dL instead of the standard 9-14 ng/dL was maintained for the first 3 months to reduce risk of toxicity. Alternative agents such as ciclosporin, sirolimus, and azathioprine were used if there was intolerance or side effects from standard immunosuppression.
| Postoperative care
Standard postoperative protocol for renal transplantation was observed with some intentional changes. Fluid replacement was calculated as urine output plus insensible losses, but aggressive fluid challenges were avoided. Meticulous control of blood pressure was undertaken with a maximum permitted systolic blood pressure at 130 mm Hg to reduce the risk of hyperfiltration and accelerated glomerulosclerosis. 
| UK regulatory framework
Transplant centers in the United Kingdom are continuously monitored for their outcome through quarterly cumulative sum 
| RE SULTS
| EKT graft survival and function
For the 30 EKTs that met inclusion criteria for this study, donor and recipient demographics are summarized in Tables 2 and 3 . One-year graft survival was 90.0% overall but 86.7% and 93.3% for the ≤5 kg and >5 kg donor categories, respectively, as shown in Figure 2A . Mann-Whitney U test).
| Delayed graft function
When the conventional definition of DGF was applied, 3 patients experienced DGF lasting up to 33 days in one case. In addition, potassium handling appeared to be a problem in some of these kidneys despite adequate creatinine clearance. Most recipients responded to medical treatment but 3 required multiple sessions of dialysis for hyperkalemia.
| Hypothermic pulsatile machine perfusion
Improvements in flush of these kidneys were observed in all cases following HMP (Figure 3 ). Often, a low flow rate and a very high resistance (as high as the maximum observable resistance value for LifePort) were observed. The resistance and the flow improved in most cases after a short period on HMP but remained significantly higher than that seen in adult kidneys. Table 4 shows the HMP parameters for 8 EKTs from ≤5 kg donors. The numbers were too small to run a statistical comparison SCS and HMP.
| Postoperative imaging
Most kidneys had high resistive indices on initial ultrasound doppler scanning. In kidneys for which perfusion was doubtful, a contrast-enhanced ultrasound scan using microbubble contrast was 
| Hyperfiltration injury
The measurement of proteinuria was not consistent during the fol- 
| D ISCUSS I ON
Our experience of EKT from pediatric donors weighing less than 20 kg shows acceptable short-medium term outcomes, supporting the use of kidneys for EKTs from these donors. Half our experiences of EKTs are from donors weighing less than 5 kg, 73% of whom were DCD donors who we regard as a special "high-risk" category of extended criteria donors at the lower extreme of age. However, 1-year graft survival in these ≤5kg donor EKTs was 86.7% compared to 93.3% in the >5 kg EKTs, which was not significantly different.
TA B L E 2 Donor characteristics, preservation and transplant outcomes in EKT
Overall (n = 30) ≤5 kg donor (n = 15) >5 kg donor (n = 15)
Age, median (range), months (unless specified) We have also demonstrated that kidneys from donors weighing less than or equal to 5 kg show progressive improvement in function over the first-year posttransplant including a statistically significant improvement between 3 and 12 months after transplantation, and therefore clinicians should not be discouraged by suboptimal graft function at 3 month after transplantation.
Among many reservations that have precluded renal transplants from very small donors, small nephron mass, risk of dysplasia, and increased risk of vascular thrombosis, hyperfiltration, and accelerated glomerulosclerosis are the most commonly cited. DCD donation has also been a deterrent for donation from this age group, but since 2015, the diagnosis of BSD was permitted in the United Kingdom for infants younger than 2 months old. 21 and is expected to lead to an expansion in the number of UK DBD donors in this age category, with limited centers undertaking such transplants. It is therefore imperative to develop guidelines for all aspects of EKT as well as collect good quality evidence for increased utilization of such organs in routine transplant practice.
During fetal development, kidneys ascend from a pelvic to lumbar position, deriving segmental blood supply at progressive stages. The development of the nephron is completed at 36 weeks of gestation TA B L E 3 Recipient characteristics F I G U R E 2 (A) Shows graft survival in EKT from donors ≤5kg compared to >5 kg demonstrating 86.7% and 93.3% 1-y survival (P = .76), respectively. B demonstrates trends in eGFR over 1, 3, 6, and 12 mo posttransplant. Median and interquartile range is denoted by the line and error bars within the individual values plotted. In the EKT from the ≤5 kg donor category, significant improvement was seen at 6 and 12 mo compared to 3 mo (3 vs 6 mo, P = .03, and 3 vs 12 mo, P = .004), which was not observed in the EKT from >5 kg donor category (3 vs 6 months, P = .17, and 3 vs 12 mo, P = .14) [Color figure can be viewed at wileyonlinelibrary. com] but the ascent of the kidneys may continue even after birth. 22 Each kidney at birth contains an estimated 0.6-1.3 million nephrons.
22,23
After birth, growth in the size of the kidneys is attributed to by hypertrophy of nephrons in response to increasing demand by the growing body. Transplanted kidneys from infants have also demonstrated growth in the transplant recipient on ultrasound scanning of EKT. 24 A direct correlation between low birthweight and low nephron numbers has also been shown, which needs to be considered when accepting kidneys from donors with birthweight less than 2.5 kg. In our experience, HMP resulted in excellent flush (Figure 3 ). An extremely high resistance and low flow were found to be a characteristic of these kidneys but did not relate to primary function F I G U R E 3 Hypothermic machine perfusion was used for neonatal and infant donor kidneys to achieve adequate flush of the kidneys. A, En bloc kidneys following in situ flush and back or DGF. The HMP parameters shown in Table 4 do not show any correlation between machine parameters and recipient outcome.
In our practice, we have not used machine parameters as a deciding factor for or against utilizing these kidneys for EKT. Recent evidence from other authors also suggest that HMP may be beneficial in EKT.
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The implantation technique ( Figure 1) was modified for the infant and neonatal kidneys and was different from the previously described Newcastle technique. In addition to vascular switch to lengthen the suprarenal aorta and IVC conduit in some cases, the vascular anastomosis was performed at right angles to the external iliac vessels. The conduits were not spatulated for the anastomosis.
No dissection was done in the hilum to identify vascular supply to the kidney. The kidneys were oriented back to front to aid access to the renal pelvis in ureter for any future intervention.
The increased risk of vascular complications with EKT is widely reported including both arterial and venous thrombosis. 20 Although there is no evidence for use in EKT, experience from simultaneous kidney pancreas transplantation supports the perioperative use of low-dose intravenous heparin with significant reduction in graft thrombosis. 28 Often, infant and neonatal donor kidneys had limited capacity for creatinine clearance and to clear potassium in an adult recipient until the kidneys hypertrophy and adapt to the demand. Creatinine levels may rise and the recipients may require several dialysis sessions for hyperkalemia despite signs of graft function. There is a need for reappraisal of the definition of DGF in EKT from these donors.
The main limitation of this study is the small cohort size, yet this is the largest reported single-center series of EKT from donors weighing less than 5 kg, including neonatal donors outside the United States. 17 This study includes the previously reported cases by the author. 6, [29] [30] [31] The US experience suggests that high-volume center experience to an extent mitigates the rates of early graft loss from these young donor kidneys and supports performing these transplants in selected centers. 32 Our program of EKTs has been a journey that involved learning from our experience of performing kidney transplants from progressively younger donors with evolution of our protocol. We believe the outcomes from such transplants are reproducible but that the procedure should be performed in centers with the drive, expertise, and adequate support. The authors also suggest sharing the waiting list of geographically contiguous recipient centers to avoid unforced breach of protocol and transplanting these kidneys into unsuitable recipients.
Due to lack of available long-term data, many aspects of EKT are driven by expert opinion and results of case series. Further research into aspects of EKT should concentrate on optimal management of blood pressure, fluid balance, immunosuppression, diagnosis, and treatment of rejection as well as the role of systemic anticoagulation.
With increasing experience, it may become possible to perform SKT in selected cases, especially in donors weighing more than 10 kg, to benefit 2 recipients. 33, 34 Training on the technical aspects of organ procurement from these donors should occur so that the retrieval surgeons are competent to procure organs from donors of this age group. Emotional support should also be provided for the members of the organ procurement team and for the team looking after the donor and the parents.
| CON CLUS ION
Renal transplants from young pediatric donors particularly those weighing less than 5 kg including neonatal donors represent an underutilized resource in kidney transplantation. This is the largest reported series outside the United States utilizing young pediatric donor kidneys with a significant proportion of neonatal donor kidneys. In our experience, the outcome of such transplants is comparable to standard-criteria donor (SCD) renal transplant. There is an increased risk of early graft loss due to vascular complications but surviving grafts achieve excellent graft function at 1 year. Focusing the experience to a limited number of centers initially with interest and expertise would likely result in better outcomes and an expansion of the potential donor pool.
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